Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $666.32 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $295.97 | 2 | $0 (2024) |
| Intera Oncology, Inc | $128.75 | 1 | $0 (2024) |
| ABBVIE INC. | $87.23 | 5 | $0 (2023) |
| Celgene Corporation | $50.11 | 3 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.28 | 2 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $16.84 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $15.91 | 1 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $14.94 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $12.29 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $243.11 | 2 | Intera Oncology, Inc ($128.75) |
| 2023 | $248.35 | 5 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($181.61) |
| 2022 | $174.86 | 10 | ABBVIE INC. ($51.34) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $114.36 | General |
| Category: Gastroenterology | ||||||
| 02/29/2024 | Intera Oncology, Inc | INTERA (Device) | Food and Beverage | In-kind items and services | $128.75 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $181.61 | General |
| Category: Gastroenterology | ||||||
| 08/25/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.91 | General |
| 02/28/2023 | ABBVIE INC. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/27/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/16/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/09/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Neuroscience | ||||||
| 11/11/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.08 | General |
| Category: Neuroscience | ||||||
| 11/05/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/27/2022 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/14/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/30/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/23/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $16.84 | General |
| 09/02/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.10 | General |
| Category: Neuroscience | ||||||
| 07/29/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 996 | 1,154 | $226,115 | $127,700 |
| 2022 | 13 | 772 | 820 | $176,329 | $98,168 |
| 2021 | 11 | 722 | 807 | $164,793 | $92,877 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 243 | 257 | $51,705 | $35,435 | 68.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 157 | 157 | $50,410 | $30,873 | 61.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 153 | 292 | $21,290 | $16,643 | 78.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 200 | 203 | $37,950 | $12,299 | 32.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 24 | 24 | $4,451 | $4,354 | 97.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 50 | 50 | $13,000 | $4,244 | 32.6% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 11 | 13 | $6,034 | $4,203 | 69.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 21 | 21 | $3,990 | $3,804 | 95.3% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 11 | 11 | $4,521 | $2,997 | 66.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 31 | 31 | $8,861 | $2,656 | 30.0% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 16 | 16 | $3,216 | $2,514 | 78.2% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 21 | 21 | $8,673 | $2,452 | 28.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $3,812 | $1,883 | 49.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 17 | 17 | $3,662 | $1,675 | 45.7% |
| 43247 | Removal of foreign bodies of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $3,842 | $1,430 | 37.2% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 14 | 14 | $700.00 | $238.52 | 34.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 141 | 143 | $44,677 | $26,849 | 60.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 74 | 76 | $15,109 | $11,694 | 77.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 95 | 95 | $16,238 | $10,819 | 66.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 18 | 18 | $8,230 | $6,359 | 77.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 68 | $8,472 | $6,163 | 72.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 120 | 120 | $21,342 | $5,967 | 28.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 71 | 99 | $7,086 | $5,505 | 77.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 27 | 27 | $5,779 | $4,711 | 81.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 27 | 27 | $10,157 | $4,566 | 45.0% |
About Michael Quinn
Michael Quinn is a Internal Medicine healthcare provider based in Christiansburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2013. The National Provider Identifier (NPI) number assigned to this provider is 1225370893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Quinn has received a total of $666.32 in payments from pharmaceutical and medical device companies, with $243.11 received in 2024. These payments were reported across 17 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($666.32).
As a Medicare-enrolled provider, Quinn has provided services to 2,490 Medicare beneficiaries, totaling 2,781 services with total Medicare billing of $318,745. Data is available for 3 years (2021–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Gastroenterology
- Location Christiansburg, VA
- Active Since 03/21/2013
- Last Updated 12/21/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225370893
Products in Payments
- XIFAXAN (Drug) $295.97
- INTERA (Device) $128.75
- ZEPOSIA (Drug) $50.11
- CREON (Drug) $29.16
- GATTEX (Drug) $22.32
- SKYRIZI (Biological) $22.18
- ENTYVIO (Biological) $21.96
- RINVOQ (Biological) $18.54
- LINZESS (Drug) $17.35
- ZENPEP (Drug) $14.94
- DIFICID (Drug) $12.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Christiansburg
Dr. Kevin Lingle, M.d, M.D
Internal Medicine — Payments: $86,192
Dr. William Thomas, Do, DO
Internal Medicine — Payments: $11,986
Dr. Benjamin Young, Md, MD
Internal Medicine — Payments: $3,689
Dr. Prajwol Pant, Md, MD
Internal Medicine — Payments: $1,249
Kaushik Kommaraju
Internal Medicine — Payments: $779.36
Ryan Curfiss, D.o, D.O
Internal Medicine — Payments: $773.18